Clinical Trials Logo

Clinical Trial Summary

The aim of this study is to show that a preemptive treatment by ganciclovir (for positive CMV viremia) or aciclovir (for positive HSV oro-pharyngeal PCR) is able to increase the number of ventilator-free days at Day 60.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT02152358
Study type Interventional
Source Assistance Publique Hopitaux De Marseille
Contact
Status Completed
Phase Phase 4
Start date February 5, 2014
Completion date April 5, 2023

See also
  Status Clinical Trial Phase
Not yet recruiting NCT05286255 - Mesenchymal Stromal Cells for COVID-19 and Viral Pneumonias Phase 1
Recruiting NCT04952337 - Clinical, Molecular and Functional Biomarkers for PROgnosis, Pathomechanisms and Treatment Strategies of COVID-19 (PROVID) - (PROVID-CAPNETZ)
Completed NCT04606407 - Inhaled NO for the Treatment of Viral Pneumonia in Adults N/A
Not yet recruiting NCT05612893 - Discover the Immune Signature of Sepsis Caused by Acute Pulmonary Infection: A Cohort Study
Not yet recruiting NCT04397497 - Mavrilimumab in Severe COVID-19 Pneumonia and Hyper-inflammation (COMBAT-19) Phase 2
Terminated NCT04345289 - Efficacy and Safety of Novel Treatment Options for Adults With COVID-19 Pneumonia Phase 3
Enrolling by invitation NCT04326036 - Use of cSVF Via IV Deployment for Residual Lung Damage After Symptomatic COVID-19 Infection Early Phase 1
Withdrawn NCT00645619 - Use of TREM-1 Protein to Differentiate Viral and Bacterial Pneumonias in Intubated Children
Completed NCT04385823 - Use of High Flow Nasal Cannula Oxygen and Covid-19 Acute Hypoxemic Respiratory Failure
Not yet recruiting NCT04876573 - Pilot Study for Cyproheptadine in Hospitalized Patient for COVID-19 Phase 2
Unknown status NCT01612572 - A Registry Study on Xiyanping(a Chinese Medicine Injection) Used in Fifty Hospitals N/A
Completed NCT04644302 - Circulatory Coherence in COVID-19 and Non-COVID-19 Patients With Sepsis
Recruiting NCT05531149 - Efficacy and Safety of Trimodulin (BT588) in Subjects With CAP Including COVID-19 Pneumonia Phase 3
Not yet recruiting NCT04955223 - Yinhu Qingwen Granule in the Treatment of Viral Pneumonia Early Phase 1
Completed NCT01868113 - Inhaled Corticosteroids in U-5 Children With Acute Respiratory Infection in Uganda: A Randomised Trial Phase 3
Recruiting NCT04380376 - Low-doses Melphalan Inhalation in Patients With COVID-19 (CoronavIrus Disease 2019) Pneumonia Phase 2
Completed NCT05386459 - Study of the Use of the Drug Ingaron in Patients With COVID-19
Not yet recruiting NCT06349707 - Multiplex PCR for Severe Respiratory Infections During the COVID-19 Pandemic
Completed NCT04394026 - Imaging Feature of SARS-CoV2 Infection
Not yet recruiting NCT04820751 - Cyproheptadine in Severe COVID-19 : A Unblinded Randomized Trial Phase 3